CASSAVA SCIENCES INC's ticker is SAVA and the CUSIP is 14817C107. A total of 174 filers reported holding CASSAVA SCIENCES INC in Q1 2022. The put-call ratio across all filers is 1.72 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $55,513 | -26.0% | 4,495 | +21.7% | 0.00% | -100.0% |
Q1 2024 | $74,972 | +11.2% | 3,695 | +23.4% | 0.00% | 0.0% |
Q4 2023 | $67,417 | +62.4% | 2,995 | +20.0% | 0.00% | – |
Q3 2023 | $41,517 | -32.1% | 2,495 | 0.0% | 0.00% | -100.0% |
Q2 2023 | $61,177 | +1.7% | 2,495 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $60,179 | -5.0% | 2,495 | +16.3% | 0.00% | 0.0% |
Q4 2022 | $63,363 | -29.4% | 2,145 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $89,704 | +48.7% | 2,145 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $60,317 | -24.3% | 2,145 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $79,665 | – | 2,145 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bleichroeder LP | 1,739,540 | $7,150,000 | 1.87% |
SPHERA FUNDS MANAGEMENT LTD. | 615,000 | $2,528,000 | 0.32% |
Worth Venture Partners, LLC | 48,535 | $200,000 | 0.12% |
Ikarian Capital, LLC | 300,000 | $1,233,000 | 0.09% |
Orbimed Advisors | 250,000 | $1,530,000 | 0.03% |
Quinn Opportunity Partners LLC | 35,687 | $147,000 | 0.02% |
BOOTHBAY FUND MANAGEMENT, LLC | 38,356 | $158,000 | 0.01% |
Jefferies Group LLC | 80,000 | $329,000 | 0.00% |
ClariVest Asset Management LLC | 33,403 | $137,000 | 0.00% |
Renaissance Technologies | 653,759 | $2,687,000 | 0.00% |